Eledon Pharmaceuticals, Inc. SEC filings ELDN
Eledon Pharmaceuticals, Inc. has 614 filings in SEC EDGAR's recent list, going back to Jun 18, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 4, 2026 | — |
| S-3 | Shelf registration | May 1, 2026 | — |
| 424B5 | Prospectus supplement | Nov 13, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Oct 30, 2024 | — |
| 424B5 | Prospectus supplement | Oct 30, 2024 | — |
| S-3 | Shelf registration | Sep 20, 2024 | — |
| 424B3 | Prospectus | Jun 6, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| S-8 | Employee stock plan registration | Aug 11, 2023 | — |
| 424B3 | Prospectus | Jun 8, 2023 | — |
| S-3 | Shelf registration | May 18, 2023 | — |
| S-3/A | Filing | May 21, 2021 | — |
| S-8 | Employee stock plan registration | Apr 12, 2021 | — |
| S-3 | Shelf registration | Mar 31, 2021 | — |
| 424B2 | Prospectus | Dec 22, 2020 | — |
| S-3 | Shelf registration | Dec 11, 2020 | — |
| 424B3 | Prospectus | Sep 15, 2020 | — |
| S-8 | Employee stock plan registration | Mar 25, 2020 | — |
| S-1 | Registration statement | Mar 25, 2020 | — |
| 424B3 | Prospectus | Jan 16, 2020 | — |
| 424B3 | Prospectus | Jan 14, 2020 | — |
| S-8 | Employee stock plan registration | Jun 28, 2019 | — |
| S-1 | Registration statement | Jun 7, 2019 | — |
| 424B5 | Prospectus supplement | May 1, 2019 | — |
| S-1/A | Amended registration statement | Sep 4, 2018 | — |
| S-1 | Registration statement | Aug 1, 2018 | — |
| S-3 | Shelf registration | Jul 23, 2018 | — |
| 424B5 | Prospectus supplement | Aug 21, 2017 | — |
| S-3/A | Filing | Aug 3, 2017 | — |
| S-3 | Shelf registration | Jun 23, 2017 | — |
| S-8 | Employee stock plan registration | Mar 3, 2017 | — |
| S-8 | Employee stock plan registration | Mar 10, 2016 | — |
| S-3 | Shelf registration | Oct 9, 2015 | — |
| S-8 | Employee stock plan registration | Mar 26, 2015 | — |
| S-8 | Employee stock plan registration | Nov 20, 2014 | — |
| 424B4 | Prospectus | Sep 18, 2014 | — |
| FWP | Free writing prospectus | Sep 17, 2014 | — |
| S-1MEF | Filing | Sep 16, 2014 | — |
| S-1/A | Amended registration statement | Sep 2, 2014 | — |
| S-1 | Registration statement | Aug 11, 2014 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELDN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Irvine, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1404281
- Former names
- Eledon Pharmaceuticals, Inc. (until Oct 30, 2026); Novus Therapeutics, Inc. (until Dec 22, 2020); Tokai Pharmaceuticals Inc (until May 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.